Over 9 million CytomX Therapeutics (CTMX) shares are reported as held by State Street.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
State Street Corporation has reported a beneficial ownership of 9,025,855 shares of CytomX Therapeutics (CTMX), representing a 4.1% stake in the company. This filing indicates that State Street holds shared voting power over 8,753,246 shares and shared dispositive power over all 9,025,855 shares, with no sole voting or dispositive power.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.